𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Three-Year Experience with Risedronate Therapy for Patients with an Increased Fracture Risk

✍ Scribed by Masayuki Takakuwa, Dr Jun Iwamoto, Koichi Itabashi

Book ID
119931371
Publisher
Springer International Publishing AG
Year
2012
Tongue
English
Weight
144 KB
Volume
32
Category
Article
ISSN
1179-1918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bone turnover markers and bone mineral d
Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence
✍ Richard Eastell; Bernard Vrijens; David L Cahall; Johann D Ringe; Patrick Garner πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 377 KB

## Abstract Surrogate markers of fracture riskβ€”bone turnover markers (BTMs) and bone mineral density (BMD)β€”can be used to monitor treatment response. We assessed whether changes in these markers greater than the least significant change (LSC) were associated with fracture risk reduction and greater